• 1
    Capocaccia R, Gatta G, Chessa E, Valente F, the EUROCARE Working Group. The EUROCARE-2 study. In: BerrinoF, CapocacciaR, EstèveJ, GattaG, HakulinenT, MicheliA, SantM, VerdecchiaA, eds. Survival of cancer patients in Europe: the EUROCARE-2 sudy, Lyon (France): IARC Scientific Publications No. 151, 1999.
  • 2
    Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, Tavilla A, the EUROCARE Working Group. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003; 14: v14v27.
  • 3
    Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 3659.
  • 4
    Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Monogr Natl Cancer Inst 1961; 6: 10121.
  • 5
    Henson DE, Ries LA. The relative survival rate. Cancer 1995; 76: 16878.
  • 6
    Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 93342.
  • 7
    Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 230716.
  • 8
    Brenner H, Arndt V, Gefeller O, Hakulinen T. An alternative approach to age adjustment of cancer survival rates. Eur J Cancer 2004; 40: 231722.
  • 9
    Brenner H, Hakulinen T, Gefeller O. Computational realization of period analysis for monitoring cancer patient survival. Epidemiology 2002; 13: 6112.
  • 10
    Arndt V, Talbäck M, Gefeller O, Hakulinen T. Modification of SAS macros for more efficient analysis of relative survival rates. Eur J Cancer 2004; 40: 7789.